D
Dynavax Technologies Corporation DVAX
$10.97 $0.090.83% NASDAQ
Recommendation
Prev Close
$10.88
Volume
1,516,664
Avg Vol (90D)
1,686,081
Market Cap
$1.28B
Dividend & Yield
--
52-Week Range
$9.20 - $14.63
P/E (TTM)
--
EPS (TTM)
-$0.38
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Dynavax Technologies Corp at Evercore ISI Healthcare Conference Transcript
12/3/2025 - GuruFocus
Dynavax Technologies (DVAX, $10.71) price may climb as it broke lower Bollinger Band on Dec 01, 2025
12/2/2025 - Tickeron - Stocks
Dynavax Technologies (DVAX, $10.71) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 1, 2025
12/2/2025 - Tickeron - Stocks
DVAX Crosses Below Key Moving Average Level
12/1/2025 - Nasdaq News: Stocks
DVAX Crosses Below Key Moving Average Level
12/1/2025 - Market News Video
Dynavax Technologies (DVAX): Exploring Current Valuation After Recent Modest Share Price Rebound
11/28/2025 - Simply Wall St
Dynavax Technologies Corporation (NASDAQ:DVAX) Given Consensus Rating of "Hold" by Brokerages
11/27/2025 - Ticker Report
First Week of July 2026 Options Trading For Dynavax Technologies (DVAX)
11/24/2025 - Stock Options Channel
Dynavax Technologies Corporation (NASDAQ:DVAX) Given Consensus Rating of "Hold" by Brokerages
11/23/2025 - MarketBeat
Bank of New York Mellon Corp Sells 199,158 Shares of Dynavax Technologies Corporation $DVAX
11/22/2025 - MarketBeat
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
11/19/2025 - PR Newswire
Los Angeles Capital Management LLC Acquires Shares of 32,350 Dynavax Technologies Corporation $DVAX
11/18/2025 - MarketBeat
Should Dynavax Technologies' (DVAX) $100 Million Buyback and Guidance Update Prompt a Reassessment by Investors?
11/17/2025 - Simply Wall St
Dynavax Technologies (DVAX, $11.16) RSI Indicator left the overbought zone on November 13, 2025
11/14/2025 - Tickeron - Stocks
Dynavax Technologies (DVAX, $11.27) RSI Indicator left the overbought zone on November 11, 2025
11/12/2025 - Tickeron - Technical Analysis
Dynavax Technologies (DVAX, $11.04) price may drop as it broke higher Bollinger Band on Nov 10, 2025
11/11/2025 - Tickeron - Stocks
Exploring Dynavax Technologies (DVAX) Valuation Following Q3 Earnings Growth and $100M Buyback Announcement
11/11/2025 - Simply Wall St
William Blair Issues Pessimistic Forecast for DVAX Earnings
11/10/2025 - MarketBeat
Dynavax Technologies (DVAX) Is Up 5.6% After Vaxart Vaccine Deal and $100 Million Buyback - What's Changed
11/9/2025 - Simply Wall St
William Blair Issues Optimistic Forecast for DVAX Earnings
11/8/2025 - MarketBeat
Dynavax Technologies Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
11/8/2025 - Simply Wall St
Dynavax Technologies (DVAX, $10.83) RSI Indicator left the overbought zone on November 07, 2025
11/8/2025 - Tickeron - Stocks
Dynavax Technologies (DVAX, $10.99) price may drop as it broke higher Bollinger Band on Nov 06, 2025
11/7/2025 - Tickeron - Stocks
Dynavax Technologies (DVAX, $10.99) RSI Indicator left the overbought zone on November 06, 2025
11/7/2025 - Tickeron - Stocks
Dynavax Technologies (DVAX, $10.99) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 6, 2025
11/7/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$330.51M
EBITDA (TTM)
$24.21M
EBIT (TTM)
$19.32M
Net Income (TTM)
-$43.40M
Balance Sheet
Total Assets (Q)
$946.51M
Total Debt (Q)
$289.22M
Total Liabilities (Q)
$412.37M
Book Value Per Share (Q)
$4.55
Cash Flow
Cash from Operations (TTM)
$90.63M
Cash from Investing (TTM)
$152.39M
Cash from Financing (TTM)
-$202.74M
Net Change in Cash (TTM)
$40.94M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
0.06
7-Day Total Return
-1.88%
30-Day Total Return
8.40%
60-Day Total Return
10.58%
90-Day Total Return
-2.83%
Year to Date Total Return
-14.96%
1-Year Total Return
-14.23%
2-Year Total Return
-21.19%
3-Year Total Return
-10.81%
5-Year Total Return
112.19%
52-week Low
Sep 15, 2025 - $9.20
52-week High
Mar 07, 2025 - $14.63
Valuation
Market Cap
$1.28B - Small Cap
Enterprise Value
$918.99M
Price/Sales (TTM)
4.49
Price/Book (Q)
2.39
Dividends and Shares
Shares Outstanding
136.47
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.dynavax.com
Phone Number
510 848 5100
Address
2100 Powell Street
EmeryVille, CA 94608
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed